Thierry Paper

Fundador en BIOSYNEX .

Fortuna: 2 M $ al 30/04/2024

61 años

Health Technology

Consumer Services

Perfil

Thierry Paper founded Biosynex SA in 2005, where he is working as Director, Deputy CEO-Research & Development from 2015.
Mr. Paper also currently works at Chembio Diagnostics, Inc., as Director from 2023, Theradiag SA, as Director from 2022, Biosynex Swiss SA, as Director, Orgenics Ltd., as Marketing Manager from 1990, and Axodev SARL, as Manager.
Mr. Paper received his Masters Business Admin degree from Ecole Nationale des Ponts et Chaussées.

Participaciones conocidas en empresas públicas

Empresa	Fecha	Número de acciones	Valoración	Fecha de valoración
BIOSYNEX SA 3.62%	31/12/2022	389 988 ( 3.62% )	2 M $	30/04/2024

Cargos activos de Thierry Paper

Empresas	Cargo	Inicio
BIOSYNEX	Fundador	15/03/2005
THERADIAG	Director/Miembro de la Junta	05/05/2022
CHEMBIO DIAGNOSTICS, INC.	Director/Miembro de la Junta	27/04/2023
Axodev SARL	Corporate Officer/Principal	-
Orgenics Ltd. Orgenics Ltd. Medical SpecialtiesHealth Technology Orgenics Ltd. develops medical diagnostic test kits for the diagnosis of infectious diseases. Its products include RapidTest, DoubleCheck, DoubleCheckGold, Clinical Chemistry, Indirect Peroxidase, Point of Care DrugCheck, BioAssay Systems, Microbiology, Veterinary and MediScreen Pipettes. The company was founded in 1982 and is headquartered in Yavne, Israel.	Ventas & Marketing	01/01/1990
Biosynex Swiss SA	Director/Miembro de la Junta	-

Todos los cargos activos de Thierry Paper

Formación de Thierry Paper.

Ecole Nationale des Ponts et Chaussées

Masters Business Admin

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Thierry Paper.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	6
Chembio Diagnostics, Inc. Chembio Diagnostics, Inc. Medical SpecialtiesHealth Technology Chembio Diagnostics, Inc. engages in the developing, manufacturing, marketing, and licensing of rapid medical tests. It offers rapid point-of-care tests for infectious, tropical and fever, and respiratory diseases, handheld analyzers, and veterinary products. The firm distributes its products to hospitals and clinics, physician offices, clinical laboratories, public health organizations, government agencies, and consumers. The company was founded in 1985 and is headquartered in Medford, NY.	Health Technology
Orgenics Ltd. Orgenics Ltd. Medical SpecialtiesHealth Technology Orgenics Ltd. develops medical diagnostic test kits for the diagnosis of infectious diseases. Its products include RapidTest, DoubleCheck, DoubleCheckGold, Clinical Chemistry, Indirect Peroxidase, Point of Care DrugCheck, BioAssay Systems, Microbiology, Veterinary and MediScreen Pipettes. The company was founded in 1982 and is headquartered in Yavne, Israel.	Health Technology
Theradiag SA Theradiag SA Medical SpecialtiesHealth Technology Theradiag SA engages in the distribution, development, and manufacturing of in vitro diagnostic and theranostics tests. It operates through the following segments: Theranostics and Diagnostics. The Theranostics segment offers solutions for patients treated with anti-tumour necrosis factor alpha. The Diagnostics segment includes products for anti-immunity, genetics, allergy, infectious disease, drug of abuse, other diagnoses, and instrumentation. The company was founded on December 29, 1986 and is headquartered in Croissy-Beaubourg, France.	Health Technology
Biosynex SA
Axodev SARL
Biosynex Swiss SA

Ver las conexiones de la empresa